: , YY
Table 1: Snapshot of GLP-1 therapeutic indications currently approved conditions and those under clinical investigation or registration
Over three decades of research have revealed a pharmacological profile that includes cardioprotection, neuroprotection, tissue repair, metabolic modulation, and immune support
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management in adults with obesity
10.1097/MPH.0000000000001734 116
Finally, in terms of treatment strategies, guidance is lacking on how to integrate CBD with modern pharmaceuticals, making it essential to develop standardized protocols for managing CKD